Aclarion, Inc. (ACON) vs Bolt Biotherapeutics, Inc. (BOLT)
A side-by-side comparison of Aclarion, Inc. and Bolt Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACON
Aclarion, Inc.
$2.29HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
BOLT
Bolt Biotherapeutics, Inc.
$3.58HealthcareDelayed quote: Oct 6, 2026, 3:08 PM EDT
Total return — ACON vs BOLT
growth of $100 · dividends reinvested · last 4yACON -100.0% (-95.1%/yr)BOLT -90.5% (-44.5%/yr)BOLT compounded faster over this window
Log scale — wide-divergence pair
ACON BOLT
ACON vs BOLT: by the numbers
- •BOLT is the larger company ($7M vs $7M market cap).
- •Both run net losses; BOLT's is the smaller (-611.47% vs -10978.48% net margin).
Metrics side by side
Valuation
| Metric | ACON | BOLT |
|---|---|---|
| P/S ratio | 78.80 | 1.46 |
| P/B ratio | 0.39 | 0.54 |
Profitability
| Metric | ACON | BOLT |
|---|---|---|
| Gross margin | -291.27% | 80.62% |
| Operating margin | -9312.55% | -450.07% |
| Net margin | -10978.48% | -611.47% |
| ROE | -54.09% | -227.37% |
| ROIC | -57.11% | -90.17% |
Growth (annualized)
| Metric | ACON | BOLT |
|---|---|---|
| Revenue CAGR (5Y) | 3.75% | N/A |
| Total return CAGR (5Y) | N/A | -57.61% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.